Medarray Awarded $1.3M in NIH Funding
April 25, 2008
Medarray, Inc. announced the award of over $1,300,000 in research grant funding from the National Institutes of Health. The company is developing a silicone hollow fiber blood oxygenator for use in long-term blood contacting applications, such as pediatric extracorporeal blood oxygenation.
"With this Phase Two Small Business Innovation and Research (SBIR) award, the NIH is recognizing the importance of improving long-term blood oxygenation," said Patrick Montoya, Medarray's President. "We continue to see progress in developing our silicone hollow fiber membrane module. Using silicone fibers for blood gas exchange avoids the wetting of pores experienced by other membranes, allowing it to be used for extended periods."
Medarray is a development-stage company commercializing dense silicone hollow fiber membranes. Using a proprietary forming process, the company creates membrane modules that can be used to add or remove gas from liquids, and to separate gases. Funded in part by grants from the National Institutes of Health, Medarray is collaborating with researchers at the University of Kentucky and the University of Michigan to use its technology within an artificial lung system.